Skip to Main Content

Paper Details

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.
Nat Commun
130
2017
B cell, B cell receptor, BTK, CLL, CLLs, PLCG2, cancer, cancer cell, chronic lymphocytic leukemia, clonal cancer cell, ibrutinib, patients
Author NameAffiliation
Dan A Landau
Dan A LandauMeyer Cancer Center & Institute of Computational Biomedicine
Dan A LandauBroad Institute
Daniel RosebrockBroad Institute
Donna NeubergDana-Farber Cancer Institute
Dimitri LivitzBroad Institute
Ignaty LeshchinerBroad Institute
Gad GetzBroad Institute
Gad GetzBroad Institute
Catherine J WuBroad Institute
Catherine J WuDana-Farber Cancer Institute
Catherine J WuHarvard Medical School
  • 1 - 12

Datasets

Release 1.2